Role of receptor for advanced glycation end products in the complication and progression of various types of cancers

Biochimica et Biophysica Acta - General Subjects

Volumn 1850, Issue 9, 2015, Pages 1898-1904

  Malik, Parth ^a   Chaudhry, Narender ^a   Mittal, Rashmi ^a   Mukherjee, Tapan K ^a  

^a MAHARISHI MARKANDESHWAR DEEMED TO BE UNIVERSITY   (India)

Author keywords

Cancer; Cancer therapy; Inflammation; Ligands; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AMINOGUANIDINE; CELL CYCLE PROTEIN; CYCLIN D1; LYSOZYME; PROTEIN BCL 2; PROTEIN KINASE B; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR;

ANGIOGENESIS; APOPTOSIS; AUTOPHAGY; BONE MARROW CELL; CANCER CELL LINE; CANCER GROWTH; CANCER RESEARCH; CELL ACTIVATION; CELL PROLIFERATION; CELL SURVIVAL; DRUG RECEPTOR BINDING; DRUG TARGETING; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SOLID TUMOR; SUPPRESSOR CELL; ANIMAL; ANTAGONISTS AND INHIBITORS; COMPLICATION; MOUSE; NEOPLASM; PHYSIOLOGY; TUMOR INVASION;

MUS;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MICE; NEOPLASM INVASIVENESS; NEOPLASMS; RECEPTORS, IMMUNOLOGIC;

EID: 84930960370     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2015.05.020     Document Type: Review

References (78)

1. M. Neeper, A.M. Schmidt, J. Brett, S.D. Yan, F. Wang, Y.C. Pan, K. Elliston, D. Stern, and A. Shaw Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins J. Biol. Chem. 267 1992 14998 15004
2. K. Sugaya, T. Fukagawa, K.I. Matsumoto, K. Mita, E.I. Takahashi, A. Ando, H. Inoko, and T. Ikemura Three genes in the human MHC class II region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3 Genomics 23 1994 408 419
3. H. Pan, L. He, B. Wang, and W. Niu The relationship between RAGE gene four common polymorphisms and breast cancer risk in northeastern Han Chinese Sci. Rep. 4 2014 4355
4. N. Demling, C. Ehrhardt, M. Kasper, M. Laue, L. Knels, and E. Rieber Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells Cell Tissue Res. 323 2006 475 488
5. T.K. Mukherjee, S. Mukhopadhyay, and J.R. Hoidal Implication of receptor for advanced glycation end product (RAGE) in pulmonary health and pathophysiology Respir. Physiol. Neurobiol. 162 2008 210 215
6. S.F. Yan, R. Ramasamy, and A.M. Schmidt Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications Nat. Clin. Pract. Endocrinol. Metab. 4 2008 285 293
7. E. Leclerc, G. Fritz, S.W. Vetter, and C.W. Heizmann Binding of S100 proteins to RAGE: an update Biochim. Biophys. Acta 1793 2009 993 1007
8. X. Wu, Y. Mi, H. Yang, A. Hu, Q. Zhang, and C. Shang The activation of HMGB1 as a progression factor on inflammation response in normal human bronchial epithelial cells through RAGE/JNK/NF-κB pathway Mol. Cell. Biochem. 380 2013 249 257
9. Z.A. Ibrahim, C.L. Armour, S. Phipps, and M.B. Sukkar RAGE and TLRs: relatives, friends or neighbours? Mol. Immunol. 56 2013 739 744
10. L. Lin RAGE on the toll road? Cell. Mol. Immunol. 3 2006 351 358
11. K. Lata, and T.K. Mukherjee Knockdown of receptor for advanced glycation end products attenuate 17α-ethinyl-estradiol dependent proliferation and survival of MCF-7 breast cancer cells Biochim. Biophys. Acta 1840 2014 1083 1091
12. H. Kuniyasu, N. Oue, A. Wakikawa, H. Shigeishi, N. Matsutani, K. Kuraoka, R. Ito, H. Yokozaki, and W. Yasui Expression of receptor for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer J. Pathol. 196 2002 163 170
13. J. Heijmans, N.V. Büller, E. Hoff, A.A. Dihal, T. van der Poll, M.A. van Zoelen, A. Bierhaus, I. Biemond, J.C. Hardwick, D.W. Hommes, V. Muncan, and G.R. van den Brink RAGE signaling promotes intestinal tumourigenesis Oncogene 32 2013 1202 1206
14. H. Liang, Y. Zhong, S. Zhou, and L. Peng Knockdown of RAGE expression inhibits colorectal cancer cell invasion and suppresses angiogenesis in vitro and in vivo Cancer Lett. 313 1 Dec 2011 91 98
15. K. Hiwatashi, S. Ueno, K. Abeyama, F. Kubo, M. Sakoda, I. Maruyama, M. Hamanoue, S. Natsugoe, and T. Aikou A novel function of the receptor for advanced glycation end-products (RAGE) in association with tumorigenesis and tumor differentiation of HCC Ann. Surg. Oncol. 15 2008 923 933
16. H. Ishiguro, N. Nakaigawa, Y. Miyoshi, K. Fujinami, Y. Kubota, and H. Uemura Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development Prostate 64 2005 92 100
17. U.K. Bhawal, Y. Ozaki, M. Nishimura, M. Suqiyama, T. Sasahira, Y. Nomura, F. Sato, K. Fujimoto, N. Sasaki, M.A. Ikeda, K. Tsuji, H. Kuniyasu, and Y. Kato Association of expression of receptor for advanced glycation end products and invasive activity of oral squamous cell carcinoma Oncology 69 2005 246 255
18. C.D. Logsdon, M.K. Fuentes, E.H. Huang, and T. Arumugam RAGE and RAGE ligands in cancer Curr. Mol. Med. 7 2007 777 789
19. C. Gebhardt, A. Riehl, M. Durchdewald, J. Nemeth, G. Furstenberger, K. Muller-Decker, A. Enk, B. Arnold, A. Bierhaus, P.P. Nawroth, J. Hess, and P. Angel RAGE signaling sustains inflammation and promotes tumor development J. Exp. Med. 205 2008 275 285
20. A. Taguchi, D.C. Blood, G. del Toro, A. Canet, D.C. Lee, W. Qu, N. Tanji, Y. Lu, E. Lalla, C. Fu, M.A. Hofmann, T. Kislinger, M. Ingram, A. Lu, H. Tanaka, O. Hori, S. Ogawa, D.M. Stern, and A.M. Schmidt Blockade of RAGE-amphoterin signaling suppresses tumor growth and metastasis Nature 405 2000 354 360
21. P. Schraml, I. Bendik, and C.U. Ludwig Differential messenger RNA and protein expression of the receptor for advanced glycosylated end products in normal lung and non-small cell lung carcinoma; Cancer Res. 57 1997 3669 3671
22. H.J. Huttunen, C. Fages, J. Kuja-Panula, A.J. Ridley, and H. Rauvala Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis Cancer Res. 62 2002 4805 4811
23. B. Bartling, H.S. Hofmann, B. Weigle, R.E. Silber, and A. Simm Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma Carcinogenesis 26 2005 293 301
24. B. Bartling, N. Demling, R.E. Silber, and A. Simm Proliferative stimulus of lung fibroblasts on lung cancer cells is impaired by the receptor for advanced glycation end-products Am. J. Respir. Cell Mol. Biol. 34 2006 83 91
25. E. Marinakis, G. Bagkos, C. Piperi, P. Roussou, and E. Diamanti-Kandarakis Critical role of RAGE in lung physiology and tumorigenesis: a potential target of therapeutic intervention? Clin. Chem. Lab. Med. 52 2014 189 200
26. B. Onyeagucha, M. Mercado-Pimentel, J. Hutchison, E. Flemingtond, and M. Nelson S100P/RAGE signaling regulates microRNA-155 expression via AP-1 activation in colon cancer Exp. Cell Res. 319 2013 2081 2090
27. T. Shimomoto, Y. Luo, H. Ohmori, Y. Chihara, K. Fujii, T. Sasahira, A. Denda, and H. Kuniyasu Advanced glycation end products (AGE) induce the receptor for AGE in the colonic mucosa of azoxymethane-injected Fischer 344 rats fed with a high-linoleic acid and high-glucose diet J. Gastroenterol. 2012 10.1007/s00535-012-0572-5
28. R. Kang, D. Tang, M. Lotze, and H. Zeh RAGE regulates autophagy and apoptosis following oxidative injury J. of Landes Bioscience 7 2011 442 444
29. S. Yamagishi, K. Nakamura, H. Inoue, S. Kikuchi, and M. Takeuchi Possible participation of advanced glycation end products in the pathogenesis of colorectal cancer in diabetic patients Med. Hypotheses 64 2005 1208 1210
30. R. Kang, T. Loux, D. Tang, N.E. Schapiro, P. Vernon, K.M. Livesey, A. Krasinskas, M.T. Lotze, and H.J. Zeh The expression of the receptor for advanced glycation end products (RAGE) is permissive for early pancreatic neoplasia Proc. Natl. Acad. Sci. 1.109 2012
31. R. Kang, D. Tang, N.E. Schapiro, T. Loux, K.M. Livesey, T.R. Billiar, H. Wang, B. Van Houten, M.T. Lotze, and H.J. Zeh The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics Oncogene 33 2014 567 577
32. S. Ghavami, I. Rashedi, B.M. Dattilo, M. Eshraghi, W.J. Chazin, M. Hashemi, S. Wesselborg, C. Kerkhoff, and M. Los S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway J. Leukoc. Biol. 83 2008 1484 1492
33. M.W. Nasser, N. Wani, D.K. Ahirwar, C.A. Powell, J. Ravi, M.M. Elbaz, H. Zhao, L. Padilla, X. Zhang, K. Shilo, M.C. Ostrowski, C.L. Shapiro, W.E. Carson, and R.K. Ganju RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironment Cancer Res. 75 2015 974 985
34. M.W. Nasser, Z. Qamri, Y.S. Deol, J. Ravi, C.A. Powell, P. Trikha, R.A. Schwendener, X.F. Bai, K. Shilo, X. Zou, G. Leone, R. Wolf, S.H. Yuspa, and R.K. Ganju S100A7 Enhances Mammary Tumorigenesis Through Upregulation of Inflammatory Pathways 10 2011 American Association for Cancer Research 1158:0008 1158:5472
35. A.M. Radia, A.M. Yaser, Ma Xiaoqian, J. Zhang, C. Yang, Q. Dong, P. Rong, B. Ye, S. Liu, and W. Wang Specific siRNA targeting receptor for advanced glycation end products (rage) decreases proliferation in human breast cancer cell lines Int. J. Mol. Sci. 14 2013 7959 7978
36. X. Hou, Z. Hu, H. Xu, J. Xu, S. Zhang, Y. Zhong, X. He, and N. Wang Advanced glycation end products trigger autophagy in cardiomyocyte via RAGE/PI3K/AKT/ mTOR pathway Cardiovasc. Diabetol. 13 2014 78
37. R. Amaravadi, and J. Lippincott-Schwartz Principles and current strategies for targeting autophagy for cancer treatment Clin. Cancer Res. 17 2011 654 666
38. M.P. Wautier, O. Chappey, S. Corda, D.M. Stern, A.M. Schmidt, and J.L. Wautier Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE Am. J. Physiol. Endocrinol. Metab. 280 2001 685 694
39. T.K. Mukherjee, S. Mukhopadhyay, and J.R. Hoidal The role of reactive oxygen species in TNFa-dependent expression of the receptor for advanced glycation end products in human umbilical vein endothelial cells Biochim. Biophys. Acta 1744 2005 213 223
40. T.K. Mukherjee, P.R. Reynolds, and J.R. Hoidal Differential effect of estrogen receptor alpha and beta agonists on the receptor for advanced glycation end product expression in human microvascular endothelial cells Biochim. Biophys. Acta 1745 2005 300 309
41. R. Kang, D. Tang, K.M. Livesey, N.E. Schapiro, M.T. Lotze, and H.J. Zeh III The receptor for advanced glycation end-products (RAGE) protects pancreatic tumor cells against oxidative injury Antioxid. Redox Signal. 15 2011 2175 2184
42. M. Kristen, K. Livesey, R. Kang, P. Vernon, and W. Buchser p53/HMGB1 complexes regulate autophagy and apoptosis Molecular and Cellular Pathobiology 2012 (10.1158. 0008-5472)
43. R. Kang, D. Tang, N. Schapirom, and K. Livesey The receptor for advanced glycation end-products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival Cell Death Differ. 17 2010 666 676
44. J.E. Chipuk, and D.R. Green Do inducers of apoptosis trigger caspase-independent cell death? Nat. Rev. Mol. Cell Biol. 6 2005 268 275
45. J.E. Chipuk, T. Kuwana, L. Bouchier-Hayes, N.M. Droin, D.D. Newmeyer, M. Schuler, and D.R. Green Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis Science 13.303 5660 2004 1010 1014
46. V. Meghnani, S.W. Vetter, and E. Leclerc RAGE overexpression confers a metastatic phenotype to the WM115 human primary melanoma cell line Biochim. Biophys. Acta (BBA) - Mol. Basis Dis. 10 2014 10.1016/j.bbadis.2014.02.013
47. S. Hoffmann, U. Friedrichs, W. Eichler, A. Rosenthal, and P. Wiedemann Advanced glycation end products induce choroidal endothelial cell proliferation, matrix metalloproteinase-2 and VEGF upregulation in vitro Graefes Arch. Clin. Exp. Ophthalmol. 240 2002 996 1002
48. K. Otero, F. Martinez, A. Beltran, D. Gonzalez, B. Herrera, G. Quintero, R. Delgado, and A. Rojas Albumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cells Biochem. J. 359 2001 567 574
49. S. Yamagishi, H. Yonekura, Y. Yamamoto, K. Katsuno, F. Sato, I. Mita, H. Ooka, N. Satozawai, T. Kawakami, M. Nomura, and H. Yamamoto Advanced glycation end products-driven angiogenesis in vitro: induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor J. Biol. Chem. 272 1997 8723 8730
50. A. Tsuji, N. Wakisaka, S. Kondo, S. Murono, M. Furukawa, and T. Yoshizaki Induction of receptor for advanced glycation end products by EBV latent membrane protein 1 and its correlation with angiogenesis and cervical lymph node metastasis in nasopharyngeal carcinoma Clin. Cancer Res. 14 2008 5368 5375
51. A. Rojas, and M.A. Morales Advanced glycation and endothelial functions: a link towards vascular complications in diabetes Life Sci. 76 2004 715 730
52. C.E. Clark, S.R. Hingorani, R. Mick, C. Combs, D.A. Tuveson, and R.H. Vonderheide Dynamics of the immune reaction to pancreatic cancer from inception to invasion Cancer Res. 67 2007 9518 9527
53. M. Ichikawa, R. Williams, L. Wang, T. Vogl, and G. Srikrishna S100A8/A9 activate key genes and pathways in colon tumor progression Mol. Cancer Res. 9 2011 133 148
54. P. Sinha, C. Okoro, D. Foell, H. Freeze, S. Ostrand-Rosenberg, and G. Srikrishnam Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells J. Immunol. 181 7 2008 4666 4675
55. M. Gnanasekar, R. Kalyanasundaram, G. Zheng, A. Chen, M.C. Bosland, and A. Kajdacsy-Balla HMGB1: a promising therapeutic target for prostate cancer Prostate Cancer 2013 157103 157111
56. P. Alexiou, M. Chatzopoulou, K. Pegklidou, and V.J. Demopoulos RAGE: a multi-ligand receptor unveiling novel insights in health and disease Curr. Med. Chem. 17 2010 2232 2252
57. Y. Yamamoto, and T. Imaizumi Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) may reflect tissue RAGE expression in diabetes Arterioscler. Thromb. Vasc. Biol. 27 2007 33 34
58. C. Cheng, K. Tsuneyama, R. Kominami, H. Shinohara, S. Sakurai, H. Yonekura, T. Watanabe, Y. Takano, H. Yamamoto, and Y. Yamamoto Expression profiling of endogenous secretory receptor for advanced glycation end products in human organs Mod. Pathol. 18 2005 1385 1396
59. I.H. Park, S.I. Yeon, J.H. Youn, J.E. Choi, N. Sasaki, I.H. Choi, and J.S. Shin Expression of a novel secreted splice variant of the receptor for advanced glycation end products (RAGE) in human brain astrocytes and peripheral blood mononuclear cells Mol. Immunol. 40 2004 1203 1211
60. G.D. Norata, K. Garlaschelli, L. Grigore, G. Tibolla, S. Raselli, L. Redaelli, G. Buccianti, and A.L. Catapano Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population Nutr. Metab. Cardiovasc. Dis. 19 2009 129 134
61. M. Hofmann, S. Drury, C. Fu, W. Qu, A. Taguchi, Y. Lu, C. Avila, N. Kambham, A. Bierhaus, and P. Nawroth RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides Cell 97 1999 889 901
62. T. Chavakis, A. Bierhaus, and P.P. Nawroth RAGE (receptor for advanced glycation end products): a central player in the inflammatory response Microbes Infect. 6 2004 1219 1225
63. R. Donato RAGE: a single receptor for several ligands and different cellular responses: the case of certain s100 proteins Curr. Mol. Med. 7 2007 711 724
64. S.S. Yan, Y.Z. Wu, H.P. Zhang, G. Furtado, X. Chen, S.F. Yan, A.M. Schmidt, C. Brown, A. Stern, J. Lafaille, L. Chess, D.M. Stern, and H. Jiang Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system Nat. Med. 9 2003 287 293
65. Y.M. Li, A.X. Tan, and H. Vlassara Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycation-modified proteins to a conserved motif Nat. Med. 1 1995 1057 1061
66. T. Mitsuhashi, Y.M. Li, S. Fishbane, and H. Vlassara Depletion of reactive advanced glycation end products from diabetic uremic sera using a lysozyme-linked matrix J. Clin. Invest. 100 1997 847 854
67. F. Zheng, W. Cai, T. Mitsuhashi, and H. Vlassara Lysozyme enhances renal excretion of advanced glycation endproducts in vivo and suppresses adverse age-mediated cellular effects in vitro: a potential AGE sequestration therapy for diabetic nephropathy? Mol. Med. 7 2001 737 747
68. M. Cocchietto, L. Zorzin, B. Toffoli, R. Candido, B. Fabris, M. Stebel, and Sava Orally administered microencapsulated lysozyme downregulates serum AGE and reduces the severity of early stage diabetic nephropathy Diabetes Metab. 34 2008 587 594
69. M. Brownlee, H. Vlassara, A. Kooney, P. Ulrich, and A. Cerami Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking Science 232 1986 1629 1632
70. T. Soulis, M.E. Cooper, S. Sastra, V. Thallas, S. Panagiotopoulos, O.J. Bjerrum, and G. Jerums Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats Diabetologia 40 1997 1141 1151
71. T. Soulis-Liparota, M.E. Cooper, D. Papazoglou, B. Clarke, and G. Jerums Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat Diabetes 40 1991 1328 1334
72. H.P. Hammes, M. Brownlee, D. Edelstein, M. Saleck, S. Martin, and K. Federlin Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat Diabetologia 37 1994 32 35
73. H.P. Hammes, D. Strodter, A. Weiss, R.G. Bretzel, K. Federlin, and M. Brownlee Secondary intervention with aminoguanidine retards the progression of diabetic retinopathy in the rat model Diabetologia 38 1995 656 660
74. B. Corman, M. Duriez, P. Poitevin, D. Heudes, P. Bruneval, A. Tedgui, and B.I. Levy Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy Proc. Natl. Acad. Sci. U. S. A. 95 1998 1301 1306
75. J.M. Forbes, L.T. Yee, V. Thallas, M. Lassila, R. Candido, K.A. Jandeleit-Dahm, M.C. Thomas, W.C. Burns, E.K. Deemer, S.M. Thorpe, M.E. Cooper, and T.J. Allen Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis Diabetes 53 2004 1813 1823
76. J.L. Wilkinson-Berka, D.J. Kelly, S.M. Koerner, K. Jaworski, B. Davis, V. Thallas, and M.E. Cooper ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat Diabetes 51 2002 3283 3289
77. R. Bucala, K.J. Tracey, and A. Cerami Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes J. Clin. Invest. 87 1991 432 438
78. A. Kuhla, J. Norden, K. Abshagen, M.D. Menger, and B. Vollmar RAGE blockade and hepatic microcirculation in experimental endotoxaemic liver failure Br. J. Surg. 100 2013 1229 1239